Hydroxyzine Hydrochloride

2192-20-3 Category:
  • #LGM Pharma is a Hydroxyzine Hydrochloride CAS# 2192-20-3 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 2192-20-3
  • AHFC code:
  • Synonyms: (+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride, 2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol dihydrochloride, AI3-50162, Alamon, Arcanax, Atarax, Atarax dihydrochloride, Ataraxoid dihydrochloride, Atazina, Aterax, Atranine A, Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine, Dichlorhydrate de 1-p.chlorbenzhydryl-4-(2-(2-hydroxyethoxy)ethyl)piperazine [French], Disron, Durrax, EINECS 218-586-3, Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-, Hydroxyzine dihydrochloride, Hydroxyzine HCl, Hydroxyzine hydrochloride, Neurolax, Orgatrax, Paxistil, Quiess, QYS, Tran-Q dihydrochloride, Tranquizine dihydrochloride, UNII-76755771U3, Vistaject, Vistarex, Vistaril, Vistaril Parenteral, Vistaril steraject, Vistazine
  • ATC Code:
  • Chemical Formula:
  • Molecular Weight: C21-H27-Cl-N2-O2.2Cl-H
  • Assay/Purity: Typically NLT 98%
  • DrugBank:
  • SMILES: O(CCN1CCN(CC1)[C,,H](c1ccccc1)c1ccc(cc1)Cl)CCO.Cl.Cl
  • InChl: InChI=1S/C21H27ClN2O2.2ClH/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25;;/h1-9,21,25H,10-17H2;2*1H
  • PubChem:
  • IUPAC: Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride

Additional Details

A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
Mode of Action:
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization


  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials